In support of this hypothesis, it was shown that SLC7A11 upregulation in GBM cells correlates with tumor invasion and a worse outcome in GBM patients, as well as with the onset of tumor-related seizures in patients (Robert et al. (2015) [273]). This evidence concerns the gene SLC7A11 and glioblastoma.